GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iNtRON Biotechnology Inc (XKRX:048530) » Definitions » Other Financing

iNtRON Biotechnology (XKRX:048530) Other Financing : ₩-6,325 Mil (TTM As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is iNtRON Biotechnology Other Financing?

iNtRON Biotechnology's Other Financing for the three months ended in Dec. 2024 was ₩-3,346 Mil.

iNtRON Biotechnology's Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-6,325 Mil.


iNtRON Biotechnology Other Financing Historical Data

The historical data trend for iNtRON Biotechnology's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iNtRON Biotechnology Other Financing Chart

iNtRON Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -56.64 -0.01 -0.01 - -

iNtRON Biotechnology Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -759.50 -2,219.13 -3,345.98

iNtRON Biotechnology Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-6,325 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iNtRON Biotechnology Other Financing Related Terms

Thank you for viewing the detailed overview of iNtRON Biotechnology's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


iNtRON Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
137, Sagimakgol-ro, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR
iNtRON Biotechnology Inc is a Korea-based company principally engaged in the biotechnology industry. It develops, manufactures, and commercializes drugs for the treatment of infectious diseases. It is contributing to national health and national prevention through several (molecular) diagnostic products such as swine flu, VRE super bacteria, food poisoning, avian influenza and foot, and mouth disease. In addition, it is also engaged in the operation of a veterinary antibiotic alternative business and new biopharmaceuticals development business.

iNtRON Biotechnology Headlines

No Headlines